R-CHOP-21 Followed by I-131 Tositumomab Consolidation in Diffuse Large B-Cell Lymphoma (DLBCL)


R-CHOP-21 Followed by I-131 Tositumomab Consolidation in Diffuse Large B-Cell Lymphoma (DLBCL)
Slides from a presentation at ASH 2010 and transcribed comments from a recent interview with Craig Moskowitz, MD (1/3/11)

Friedberg JW et al. R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): Southwest Oncology Group protocol S0433. Proc ASH 2010;Abstract 590.

Dr Moskowitz is Clinical Director of the Division of Hematologic Oncology at Memorial Sloan-Kettering Cancer Center in New York, New York.